Clinical studies Lindsay G et al.
The clinical effectiveness of Gelclair® in the management of oral mucositis
  • The Linsay et al. study demonstrated a significant efficacy of Gelclair® in reducing pain scores in 33 head and neck cancer patients with oral mucositis receiving radiotherapy. 
  • After Gelclair® treatment, pain score was reduced by 57% after a maximum of 4 days of treatment, providing pain relief in 85% of patients.  

Graf A.jpg

  • Gelclair® was well tolerated and effective in reducing pain associated with oral mucositis.


Lindsay G et al.Australian Nursing Journal 2009; 16(9):30-3.


HELSINN This website is for Ex U.S. residents only Last Update: 19.02.2018
Sitemap Privacy and Cookies Policy Terms of Use